Enwei Pharmaceuticals: plans to invest 20 million yuan to jointly establish a fund.

On November 14th, Enwei Pharmaceuticals announced that the company recently signed a partnership agreement with Shanghai Panlin Hongyu Enterprise Management Partnership Enterprise, Tangshan Jinkun Chemical Co., Ltd., Li Jiaojiao, etc. The agreement states that the company will subscribe to the investment fund shares with a capital of 20 million RMB as a limited partner, accounting for 9.95%. The partnership will focus on investing in early and growth-stage enterprises, with investment directions including medical and technology sectors.